Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,392 | 19,602 | 14,311 | 18,805 | 52,713 |
| Marketable Securities | 76,029 | 86,013 | 130,983 | 148,669 | 142,213 |
| Receivables | 1,774 | 2,551 | 2,405 | 2,144 | 5,116 |
| TOTAL | $117,561 | $111,683 | $153,113 | $174,767 | $203,285 |
| Non-Current Assets | |||||
| PPE Net | 4,511 | 5,015 | 4,961 | 5,633 | 6,304 |
| Investments And Advances | 2,320 | 2,654 | 2,780 | 2,995 | 2,781 |
| Intangibles | 0 | 0 | 0 | 0 | 10,513 |
| Other Non-Current Assets | 9,405 | 9,762 | 10,097 | 9,703 | 10,156 |
| TOTAL | $16,236 | $17,431 | $17,838 | $18,330 | $29,754 |
| Total Assets | $133,797 | $129,114 | $170,951 | $193,097 | $233,038 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,556 | 18,201 | 20,918 | 16,266 | 22,952 |
| Accrued Expenses | 5,500 | 3,023 | 2,365 | 5,011 | 6,172 |
| TOTAL | $26,400 | $23,401 | $42,570 | $43,711 | $51,932 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 22 | 22 | 109 | 3,828 | 3,749 |
| Other Non-Current Liabilities | 10,658 | 11,271 | 11,032 | 11,195 | 11,702 |
| TOTAL | $10,658 | $11,271 | $11,032 | $11,227 | $11,734 |
| Total Liabilities | $37,058 | $34,672 | $53,602 | $54,938 | $63,666 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,964 | 25,911 | 23,370 | 22,740 | 22,331 |
| Common Shares | 26 | 23 | 23 | 270 | 268 |
| Retained earnings | -1,685,672 | -1,653,435 | -1,622,965 | -1,597,962 | -1,564,032 |
| Other shareholders' equity | -690 | -676 | -663 | -751 | -691 |
| TOTAL | $96,739 | $94,442 | $117,349 | $138,160 | $169,372 |
| Total Liabilities And Equity | $133,797 | $129,114 | $170,951 | $193,097 | $233,038 |